| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |